Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wickenden

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
American Journal of Physiology. Cell Physiology|May 12, 2010
Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilationT G Banke, S R Chaplan, A D Wickenden
PLOS Global Public Health|March 24, 2023
How do people with disabilities in three regions of Guatemala make healthcare decisions? A qualitative study focusing on use of primary healthcare servicesGoli Hashemi, Mary Wickenden, Ana Leticia Santos, et al.
Global Health Action|September 10, 2015
What can we learn about postnatal care in Ghana if we ask the right questions? A qualitative studyZelee Hill, Eunice Okyere, Mary Wickenden, et al.
Current Pharmaceutical Design|June 13, 2009
HCN pacemaker channels and pain: a drug discovery perspectiveA D Wickenden, M P Maher, S R Chaplan
British Journal of Pharmacology|June 1, 1988
The physiological relevance of low agonist affinity binding at opioid mu-receptorsJ A Carroll, J S Shaw, A D Wickenden
The Journal of the Maine Medical Association|December 1, 1979
Intraosseus ganglionP E Giustra, R W Wickenden, P J Killoran
Biochemical Pharmacology|February 20, 2017
Potentiating SLC transporter activity: Emerging drug discovery opportunitiesMarie-Laure Rives, Jonathan A Javitch, Alan D Wickenden
African Journal of Disability|July 22, 2017
Stakeholder consultations on community-based rehabilitation guidelines in Ghana and UgandaMary Wickenden, Diane Mulligan, Gertrude O Fefoame, et al.
Journal of Virological Methods|February 1, 1987
Cross-hybridisation of human papillomavirus DNA on filtersC Wickenden, D V Coleman, B Evans, et al.
The Biochemical Journal|March 1, 1984
Proteolysis of ankyrin and of band 3 protein in chemically induced cell fusion. Ca2+ is not mandatory for fusionR D Lang, C Wickenden, J Wynne, et al.
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
American Journal of Physiology. Cell Physiology|May 12, 2010
Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilationT G Banke, S R Chaplan, A D Wickenden
PLOS Global Public Health|March 24, 2023
How do people with disabilities in three regions of Guatemala make healthcare decisions? A qualitative study focusing on use of primary healthcare servicesGoli Hashemi, Mary Wickenden, Ana Leticia Santos, et al.
Global Health Action|September 10, 2015
What can we learn about postnatal care in Ghana if we ask the right questions? A qualitative studyZelee Hill, Eunice Okyere, Mary Wickenden, et al.
Current Pharmaceutical Design|June 13, 2009
HCN pacemaker channels and pain: a drug discovery perspectiveA D Wickenden, M P Maher, S R Chaplan
British Journal of Pharmacology|June 1, 1988
The physiological relevance of low agonist affinity binding at opioid mu-receptorsJ A Carroll, J S Shaw, A D Wickenden
The Journal of the Maine Medical Association|December 1, 1979
Intraosseus ganglionP E Giustra, R W Wickenden, P J Killoran
Biochemical Pharmacology|February 20, 2017
Potentiating SLC transporter activity: Emerging drug discovery opportunitiesMarie-Laure Rives, Jonathan A Javitch, Alan D Wickenden
African Journal of Disability|July 22, 2017
Stakeholder consultations on community-based rehabilitation guidelines in Ghana and UgandaMary Wickenden, Diane Mulligan, Gertrude O Fefoame, et al.
Journal of Virological Methods|February 1, 1987
Cross-hybridisation of human papillomavirus DNA on filtersC Wickenden, D V Coleman, B Evans, et al.
The Biochemical Journal|March 1, 1984
Proteolysis of ankyrin and of band 3 protein in chemically induced cell fusion. Ca2+ is not mandatory for fusionR D Lang, C Wickenden, J Wynne, et al.
Pageof 20